Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technegas vs Xenon-133 for Lung Ventilation Imaging
NCT03054870Phase 3Terminated
- Sponsor
- Cyclomedica
- Start
- Sep 2017
- Primary completion
- Sep 2020
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of Technegas in pulmonary embolism (PE), sponsored by Cyclomedica. Primary endpoint: Blinded Readers Percent Agreement (PA) for Matching Image Views at 5 months. Started Sep 2017; status: terminated.
02
Drugs
Technegas
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT03054870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054870.